102 STAT. 4282
President of U.S.
PUBLIC LAW 100-690—NOV. 18, 1988
"(II) in preventing narcotic and psychotropic drugs and other controlled substances produced or processed, in whole or in part, in such country or transported through such country, from being sold illegally within the jurisdiction of such country to United States Government personnel or their dependents or from being transported, directly or indirectly, into the United States, "(III) in preventing and punishing the laundering in that country of drug-related profits or drug-related moneys, and "(IV) in preventing and punishing bribery and other forms of public corruption which facilitate the production, processing, or shipment of narcotic and psychotropic drugs and other controlled substances, or which discourage the investigation and prosecution of such acts; or "(ii) for a country that would not otherwise qualify for certification under clause (i), the vital national interests of the United States require that subsection (a) not be applied with respect to that country. "(B) A bilateral narcotics agreement referred to in subparagraph (A)(i)(I) is an agreement between the United States and a foreign country in which the foreign country agrees to take specific activities, including, where applicable, efforts to— "(i) reduce drug production, drug consumption, and drug trafficking within its territory, including activities to address illicit crop eradication and crop substitution; "(ii) increase drug interdiction and enforcement; "(iii) increase drug treatment; "(iv) increase the identification of and elimination of illicit drug laboratories; "(v) increase the identification and elimination of the trafficking of precursor chemicals for the use in production of illegal drugs; "(vi) increase cooperation with United States drug enforcement officials; and "(vii) where applicable, increase participation in extradition treaties, mutual legal assistance provisions directed at money laundering, sharing of evidence, and other initiatives for cooperative drug enforcement. "(C) A country which in the previous year was designated as a major drug producing country or a major drug-transit country may not be determined to be cooperating fully under subparagraph (A)(i) unless it hgis in place a bilateral narcotics agreement with the United States or a multilateral agreement which achieves the objectives of subparagraph (B). "(D) If the President makes a certification with respect to a country pursuant to subparagraph (A)(ii), he shall include in such certification— "(i) a full and complete description of the vital national interests placed at risk if action is taken pursuant to subsection (a) with respect to that country; and "(ii) a statement weighing the risk described in clause (i) against the risks posed to the vital national interests of the United States by the failure of such country to cooperate fully with the United States in combating narcotics or to take adequate steps to combat narcotics on its own. "(E) The President may make a certification under subparagraph (A)(i) with respect to a major drug producing country or drug-transit
�
